Point-of-Care product revenue of $4.6 million grew 119% Y/Y and +53% Q/Q-
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech to Announce Q2 2024 Financial Results
- Trinity Biotech Granted Nasdaq Compliance Extension
- Trinity Biotech Forecasts Strong Growth and UK Expansion
- Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements
- Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience